Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to $494.0 million.

  • Indivior Pharmaceuticals' Non-Current Assets changed N/A to $494.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year change of. This contributed to the annual value of $489.0 million for FY2024, which is 2923.3% down from last year.
  • Latest data reveals that Indivior Pharmaceuticals reported Non-Current Assets of $494.0 million as of Q3 2025.
  • In the past 5 years, Indivior Pharmaceuticals' Non-Current Assets registered a high of $691.0 million during Q4 2023, and its lowest value of $388.0 million during Q4 2021.
  • Over the past 5 years, Indivior Pharmaceuticals' median Non-Current Assets value was $494.0 million (recorded in 2025), while the average stood at $509.3 million.
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Non-Current Assets surged by 3549.02% in 2023, and later plummeted by 2923.3% in 2024.
  • Over the past 5 years, Indivior Pharmaceuticals' Non-Current Assets (Quarter) stood at $388.0 million in 2021, then soared by 31.44% to $510.0 million in 2022, then soared by 35.49% to $691.0 million in 2023, then dropped by 29.23% to $489.0 million in 2024, then rose by 1.02% to $494.0 million in 2025.
  • Its Non-Current Assets stands at $494.0 million for Q3 2025, versus $501.0 million for Q2 2025 and $492.0 million for Q1 2025.